Article Information
History
- May 29, 2020.
Article Versions
- Version 1 (May 12, 2020 - 22:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Atreyee Basu1,
- Tatyana Zinger1,
- Kenneth Inglima2,
- Kar-mun Woo3,
- Onome Atie3,
- Lauren Yurasits3,
- Benjamin See2 and
- Maria E. Aguero-Rosenfeld1,*
- 1NYU Grossman School of Medicine, Department of Pathology, New York, NY, USA
- 2NYU Langone Health, Tisch Hospital New York, NY, USA
- 3NYU Grossman School of Medicine, Department of Emergency Medicine, New York, NY, USA
- ↵*Corresponding author: Maria E. Aguero-Rosenfeld, Address: NYU Langone Health, Tisch Hospital Clinical Laboratories, 560 First Avenue, New York, N.Y. 10016, Telephone: (212) 263-5905, Fax number: (212) 263-7922, E-mail address: Maria.Aguero-Rosenfeld{at}nyulangone.org
Posted May 29, 2020.
Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution
